Cefepime/enmetazobactam: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 31: | Line 31: | ||
{{Pharmacology-stub}} | {{Pharmacology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 06:34, 17 March 2025
Cefepime/enmetazobactam is a combination of two antibiotics, cefepime and enmetazobactam, used in the treatment of various bacterial infections. This combination is particularly effective against Gram-negative bacteria due to the synergistic effects of the two drugs.
Cefepime[edit]
Cefepime is a fourth-generation cephalosporin antibiotic. It is broad-spectrum, meaning it is effective against a wide range of bacteria. Cefepime works by inhibiting the synthesis of the bacterial cell wall, leading to cell death.
Enmetazobactam[edit]
Enmetazobactam is a beta-lactamase inhibitor. Beta-lactamase is an enzyme produced by some bacteria that provides resistance to beta-lactam antibiotics like cefepime. By inhibiting this enzyme, enmetazobactam allows cefepime to work more effectively.
Clinical Use[edit]
Cefepime/enmetazobactam is used to treat a variety of infections caused by Gram-negative bacteria, including urinary tract infections, pneumonia, and intra-abdominal infections. It is also used in the treatment of sepsis and meningitis.
Side Effects[edit]
Like all medications, cefepime/enmetazobactam can cause side effects. These may include nausea, vomiting, diarrhea, and rash. In rare cases, it can cause more serious side effects such as seizures and Clostridium difficile-associated diarrhea.
See Also[edit]
| This article is a stub. You can help WikiMD by registering to expand it. |
